Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus

Imiquimod is a recently developed imidazoquinolin heterocyclic amine that i s an immune response modifier. Treatment with topical 5% imiquimod cream ha s shown promising results in the treatment of genital warts in immunocompet ent individuals. We report here the first case of successful treatment with topical 5% imiquimod cream of facial verrucae in an individual with human immunodeficiency virus.